|
The 2012 edition of the Omnicare Geriatric Pharmaceutical Care Guidelines® is online in a web-based format for the first
time! Navigation through the individual monographs couldn’t be easier given the site organization, Home
Page, FAQs, and Search features. Users have the option of reading on-line or creating their own compilation of
items from one or several monographs as a PDF file for printing. The Omnicare Guidelines® are formatted for
compatibility with iPADs, MACs, and Microsoft operating systems with plans to offer a mobile application in
2013. Omnicare customers benefit from access to the Omnicare Geriatric Pharmaceutical Care Guidelines® through links from Omniview
and OmniviewDr.
Users benefit from the most comprehensive source of geriatric-focused pharmaceutical
information. Medication therapies are rated by clinical effectiveness, safety and relative cost, followed by
detailed discussions of clinical evidence and therapeutic use of medications for almost 50 common conditions
in seniors. The online Omnicare Geriatric Pharmaceutical Care Guidelines® contains the text, reference tables and lists, treatment
algorithms and critical pathways previously available in textbook format. Also new in 2012 are algorithms for
discontinuing Antipsychotic Medications, discontinuing Proton Pump Inhibitors, treatment of Benign Prostatic
Hyperplasia, treatment of Restless Leg Syndrome and discontinuing Sliding Scale Insulin.
The Clinical Tools tab contains other resources to help integrate appropriate medication management into
the entire Resident Care process.
Drug-Related Changes of Condition tables
Cytochrome P450 Enzyme System and Medications
Drugs with Boxed Warnings (with indication of these drugs in the formulary ranking tables)
Guidance on Dosage Adjustments based upon age, renal and hepatic Function
Photosensitivity of Drug Agents
Drug Administration recommendations regarding food
Medications with the potential for significant Anticholinergic symptoms
Medications for which Blood Pressure and Pulse Monitoring are recommended
Common Oral Dosage forms that should not be crushed
Suggested Laboratory Monitoring Parameters for selected medications
Clinical Evaluation and Review of the 2012 GPCG was completed by:
The Geriatric Pharmacy Institute of the Philadelphia College of Pharmacy, at the University of the Sciences
in Philadelphia
American Geriatrics Society
Omnicare Pharmacy and Therapeutics Committee
76 content experts including Physicians, Certified Medical Directors, Psychiatric Specialists, Geriatric Nurse
Practitioners, Consultant Pharmacists, and Certified Geriatric Pharmacists
|